Not Yet RecruitingNot Applicable

Predictive and Diagnostic Value of BIND Score in Assessment of Severe Neonatal Jaundice Cases in Neonatal Intensive Care Unit

80 participantsStarted 2025-10-01

Plain-language summary

Early detection and prevention of neonatal encephalopathy using BIND score.

Who can participate

Age range1 Day – 28 Days

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: Newborn \< 28 days old Neonates with severe hyperbilirubinemia need extensive phototherapy impending exchange transfusion Exclusion criteria: Age \> 28 days old Neonates with any abnormal neurological signs suggesting neurological disease (hypoxic ischemic encephalopathy, muscle disease, …etc.).

What they're measuring

Decrease high billirubin level

Timeframe: One year duration

Predictive and diagnostic value of BIND score in assessment of severe neonatal jaundice cases in NICU

Timeframe: Baseline

Predictive and diagnostic value of BIND score in assessment of severe neonatal jaundice cases in NICU

Timeframe: Baseline

Trial details

NCT IDNCT07150494

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-10-01

Contact for this trial

Nouralhoda Ahmed Metwally

+201012527376 nouralhoda2712@gmail.com

View on ClinicalTrials.gov More Neonatal Hyperbilirubinemia trials